40 Units of Mounjaro: How Many mg Does That Equal?

Every Mounjaro KwikPen strength has its own concentration: the unit-to-mg ratio is not the same across all strengths, so a unit count means nothing without knowing which pen you are measuring from.
The 10 mg KwikPen contains 80 units total (3.125 mg/ml × 3.2 ml), so 40 units from that pen represents exactly one 10 mg weekly dose split in two — not a recognised dose interval.
Mounjaro's licensed titration schedule runs from 2.5 mg up to 15 mg in steps set by the prescriber; dose and timing decisions are clinical, not mathematical.
Only a GPhC-registered Independent Prescriber can advise on your correct dose, do not adjust based on unit conversions alone.

Forty units drawn from a Mounjaro KwikPen equals 10 mg of tirzepatide. Each pen contains 3.2 ml of solution at a concentration of 3.125 mg/ml, and its full 80-unit volume delivers a single 10 mg weekly dose. If you are counting units rather than reading the pen's dose label, it helps to understand why that number appears — and why the unit count alone tells you less than you might expect. Mounjaro is a prescription-only medicine; any dose change must be directed by a prescriber, not calculated independently.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Why Unit Counting Causes Confusion, and What the Numbers Actually Mean

The biggest misconception: units are a universal measuring system for Mounjaro

The most common mistake people make when looking up this conversion is assuming that "units" means the same thing across every Mounjaro pen, the way insulin units are standardised. They are not. Mounjaro KwikPens are fixed-dose devices: you press the injector once and deliver one complete weekly dose. You do not draw up a syringe, and the pen does not have a graduated scale you dial to a unit count. So where does the "40 units" figure come from?

It typically comes from one of two places. First, people who have seen a syringe-based compounded product labelled in units and are trying to map that onto the branded pen. Second, people who have done a rough calculation using the pen's concentration and are checking their arithmetic. Either way, the relevant fact is this: the branded 10 mg Mounjaro KwikPen holds 3.2 ml at 3.125 mg/ml, giving a total of 80 units of solution, and a single 10 mg weekly dose uses all 80. Forty units would be half the pen's contents, which does not correspond to any step on the licensed dosing ladder.

The NHS medicines page for tirzepatide describes Mounjaro clearly as a fixed-dose injector rather than a titrated syringe, which is why unit arithmetic produces numbers that have no clinical home.

The actual dose each Mounjaro strength contains

There are six licensed UK strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg. Each is a separate KwikPen with its own concentration, so the volume of solution and the implied "unit count" differ for every strength. The 2.5 mg pen, for example, holds a different concentration entirely from the 10 mg pen, meaning that 40 units drawn from a 2.5 mg pen would represent a far smaller mass of tirzepatide than 40 units from a 10 mg pen.

This is exactly why the unit count for the 5 mg pen looks different to the figure people find when researching the 10 mg version. The pen, the concentration and the total volume all change between steps.

Treatment starts at 2.5 mg, a dose chosen to let the body adjust gradually, not to produce weight loss at that level. The prescriber then reviews progress before any step up. If you are curious how those earlier doses convert, you can read about how many units make up the 2.5 mg starting dose and the 7.5 mg figure are covered separately, and what the 2.5 mg Mounjaro pen works out to in units is explained in full on its own page. Picking the right calculation requires knowing which pen you are actually looking at.

Tirzepatide is tirzepatide: the same molecule, same maths

Mounjaro is the UK brand name for tirzepatide, so the unit conversion for 40 units of Mounjaro and 40 units of tirzepatide are the same question. Some patients encounter the INN (international non-proprietary name) tirzepatide on their prescription or on online information, and wonder if the numbers differ. They do not: the active ingredient, the concentrations and the pen specifications are identical.

For context on where 10 mg sits in the overall treatment journey, the 5 mg dose page explains what changes clinically as the dose steps up from the initial pen. The cost of treatment at different doses is another question entirely; a fair overview of what private Mounjaro treatment typically involves can be found on our weight-loss treatments page.

It is also worth knowing that if you are doing these calculations because you are converting from a compounded or unlicensed tirzepatide product, the concentrations may be entirely different from the branded pen, which is one reason clinical oversight matters at every step. Compounded products fall outside the licensed supply chain and the MHRA's approval process.

What to do if your dose doesn't feel right

If you are researching unit conversions because you are unsure whether you have taken the right amount, or because something about your pen seems off, the right move is to contact your prescriber before your next injection. A quick phone call on a Monday morning (or a message through your service's aftercare) costs nothing and avoids the guesswork that unit arithmetic can introduce.

Bank holidays and holiday periods do occasionally throw off injection timing for people who order monthly. If your supply is running short or you are approaching a dose-review point, plan ahead rather than trying to split or extend a pen. Splitting a fixed-dose KwikPen to eke out extra doses is not how the device is designed and risks inaccurate dosing.

Our prescribers are available seven days a week for aftercare questions. If you are not yet on treatment and want a clinical conversation about which dose might be appropriate for your situation, the right starting point is our free consultation. A real prescriber reviews every submission, the clinical team page has more on who that is. Speak to our prescribers if the unit question is really a dose-review question in disguise.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions